Top Markets
Coin of the day
Firebrick Pharma Limited Firebrick Pharma Limited

Firebrick Pharma Limited

FRE
Rangering i aksjer #35032
Firebrick Pharma Limited, an enterprise established in 2012 and headquartered... Firebrick Pharma Limited, an enterprise established in 2012 and headquartered in Melbourne, Australia, is dedicated to the research, development, and market launch of Nasodine, a nasal spray treatment for the common cold, exclusively for the Australian market.
Aksjekurs
$0.01904269
Sist synkronisert: 2026-08-14
Markedsverdi
$4.55M
Endring (1 dag)
0.00%
Endring (1 år)
-63.41%
Land
AU
Handel Firebrick Pharma Limited (FRE)

Kategori

Aksjeprishistorikk for Firebrick Pharma Limited (FRE)
Høyeste sluttskurs: $0.02 den 2026-08-01

Laveste sluttskurs: $0.41 den 2022-01-01
Aksjeprishistorikk for Firebrick Pharma Limited fra 2022 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -6.11%
2025 -0.27%
2024 -2.24%
2023 -77.14%
2022 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$1.18K 68.58%
US
$260.38 47.41%
US
$249.16 20.55%
US
$470.54 41.86%
CH
$135.64 61.07%
US